Your browser doesn't support javascript.
Hydroxychloroquine for the treatment of COVID-19: the importance of scrutiny of positive trials.
Chow, Ronald; Simone, Charles B; Lock, Michael.
  • Chow R; Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada. ronald.chow@uwo.ca.
  • Simone CB; Department of Radiation Oncology, New York Proton Center, New York, NY, USA.
  • Lock M; Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada.
Ann Palliat Med ; 9(6): 3716-3720, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-761207
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Ann Palliat Med Year: 2020 Document Type: Article Affiliation country: Apm-20-1538

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Ann Palliat Med Year: 2020 Document Type: Article Affiliation country: Apm-20-1538